Clinical Trials Logo

Schizophrenic Disorder clinical trials

View clinical trials related to Schizophrenic Disorder.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03010865 Withdrawn - Clinical trials for Cognitive Impairment

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Start date: June 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this grant is to evaluate the efficacy of sodium butyrate as a novel treatment for cognitive deficits in schizophrenia (SZ). The aims will be to evaluate its effects on improving symptoms and functioning in SZ, and the relationship of the drug's clinical effects to epigenetic and inflammation related biochemical changes.